# ACETAMINOPHEN

NDC: 62207-183
Generic name: ACETAMINOPHEN
Labeler / Manufacturer: Granules India Limited
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20190418

FDA application: ANDA211544

## Active ingredients

- ACETAMINOPHEN: 650 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62207-183"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62207-183
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00eb3e4b-1507-4c9a-83a5-ef50cb312753